Allergan to buy out Kythera Biopharma for $2.1bn
Wednesday, June 24, 2015 - 08:20
in Mathematics & Economics
Acquisition strengthens firm's position in cosmetic treatments with only drug approved for a 'double chin'
Acquisition strengthens firm's position in cosmetic treatments with only drug approved for a 'double chin'